youtube_live
Q3 2026 earnings • released • EPS beat +11,45% • Revenue beat +3,01%
See resultschevron_right
AMG:ETR
Amgen Inc
418,15 €
arrow_downward
-1,26%(-5,35) 1D
5 ნოე, 17:35:54 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMG...
Open
423,95 €
High
431,20 €
Low
418,15 €
Mkt. cap
253,62 მლრ.
Avg. vol.
510,00
Volume
668,00
52-wk high
438,75 €
52-wk low
263,60 €
No. of employees
32 ათ.
Open
423,95 €
High
431,20 €
Low
418,15 €
Mkt. cap
253,62 მლრ.
Avg. vol.
510,00
Volume
668,00
52-wk high
438,75 €
52-wk low
263,60 €
No. of employees
32 ათ.
News stories
From web sources and news partners
The Motley Fool
·
1 საათის წინ
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?
GuruFocus
·
18 საათის წინ
Amgen Inc (AMGN) Shares Surge 3.7% -- What GF Score of 85 Tells Investors
marketscreener.com
·
22 საათის წინ
Amgen's Diversified Base Business Warrants Higher Multiple, UBS Says
Investing.com
·
1 დღის წინ
UBS raises Amgen stock price target to $530 on diversification
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEOრობერტ ეი ბრედუეი
Employees31,5 ათ.
Founded1980
Headquartersთაუზენდ-ოუკსი, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Industry-
Websiteamgen.com